Cargando…

Digital Health Technologies Applied by the Pharmaceutical Industry to Improve Access to Noncommunicable Disease Care in Low- and Middle-Income Countries

BACKGROUND: There is limited research on how digital health technologies (DHTs) are used to promote access to care for patients with noncommunicable diseases (NCDs), particularly in low- and middle-income countries (LMICs). We describe the use of DHTs in pharmaceutical industry–led access programs a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heerdegen, Anne Christine Stender, Cellini, Carlotta Maria, Wirtz, Veronika J., Rockers, Peter C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Health: Science and Practice 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622287/ https://www.ncbi.nlm.nih.gov/pubmed/36316151 http://dx.doi.org/10.9745/GHSP-D-22-00072

Ejemplares similares

Evaluation of pharmaceutical industry-led access programmes: a standardised framework
por: Rockers, Peter C, et al.
Publicado: (2019)

Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist
por: Umeh, Chukwuemeka A., et al.
Publicado: (2020)

Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunities
por: Kaplan, Warren A., et al.
Publicado: (2023)

Integration of HIV and Noncommunicable Diseases in Health Care Delivery in Low- and Middle-Income Countries
por: Nigatu, Tilahun
Publicado: (2012)

A Methodology for Mapping the Patient Journey for Noncommunicable Diseases in Low- and Middle-Income Countries
por: Bharatan, Tanaya, et al.
Publicado: (2021)

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
por: Minaei, Hossein, et al.
Publicado: (2019)

Moving the Agenda on Noncommunicable Diseases: Policy Implications of Mobile Phone Surveys in Low and Middle-Income Countries
por: Pariyo, George W, et al.
Publicado: (2017)

Noncommunicable Diseases Prevention In Low- and Middle-Income Countries: An Overview of Health in All Policies (HiAP)
por: Ndubuisi, Nweke Ebele
Publicado: (2021)

Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review
por: Foo, Chuan De, et al.
Publicado: (2022)

An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries
por: Jailobaeva, Kanykey, et al.
Publicado: (2021)

Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review
por: Islam, Md. Deen, et al.
Publicado: (2019)

The costs of diabetes treatment in low- and middle-income countries: a systematic review
por: Moucheraud, Corrina, et al.
Publicado: (2019)

Mobilising stakeholders to improve access to state-of-the-art radiotherapy in low- and middle-income countries
por: Chofor, Ndimofor, et al.
Publicado: (2021)

Socioeconomic inequality in the prevalence of noncommunicable diseases in low- and middle-income countries: Results from the World Health Survey
por: Hosseinpoor, Ahmad Reza, et al.
Publicado: (2012)

Diet and Physical Activity for the Prevention of Noncommunicable Diseases in Low- and Middle-Income Countries: A Systematic Policy Review
por: Lachat, Carl, et al.
Publicado: (2013)

Using mHealth to Predict Noncommunicable Diseases: A Public Health Opportunity for Low- and Middle-Income Countries
por: Rosskam, Ellen, et al.
Publicado: (2017)

Implementation research on noncommunicable disease prevention and control interventions in low- and middle-income countries: A systematic review
por: Hategeka, Celestin, et al.
Publicado: (2022)

Transforming capacity-strengthening in an era of sustainable development
por: Heerdegen, Anne Christine Stender
Publicado: (2020)

Medical device landscape for communicable and noncommunicable diseases in low-income countries
por: Sabet Sarvestani, Amir, et al.
Publicado: (2018)

Sustainable development goals applied to digital pathology and artificial intelligence applications in low- to middle-income countries
por: Piya, Sumi, et al.
Publicado: (2023)

Applying an environmental public health lens to the industrialization of food animal production in ten low- and middle-income countries
por: Lam, Yukyan, et al.
Publicado: (2019)

Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya
por: Rockers, Peter C, et al.
Publicado: (2018)

Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis
por: Lee, John Tayu, et al.
Publicado: (2015)

The Impact of COVID-19 on the Care of Patients With Noncommunicable Diseases in Low- and Middle-Income Countries: An Online Survey of Patient Perspectives
por: Devi, Ratna, et al.
Publicado: (2021)

Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay?
por: Galárraga, Omar, et al.
Publicado: (2013)

Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
por: Kaplan, Warren A., et al.
Publicado: (2017)

The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries
por: Bullen, Chris, et al.
Publicado: (2021)

How is implementation research applied to advance health in low-income and middle-income countries?
por: Alonge, Olakunle, et al.
Publicado: (2019)

Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
por: Nebot Giralt, Ariadna, et al.
Publicado: (2020)

Prioritizing Health-Sector Interventions for Noncommunicable Diseases and Injuries in Low- and Lower-Middle Income Countries: National NCDI Poverty Commissions
por: Gupta, Neil, et al.
Publicado: (2021)

Improving access to SLE therapies in low and middle-income countries
por: Mendoza-Pinto, Claudia, et al.
Publicado: (2023)

Access to safe blood in low-income and middle-income countries: lessons from India
por: Jenny, Hillary E, et al.
Publicado: (2017)

The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries
por: Morgan, Steven G., et al.
Publicado: (2017)

The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses
por: Marshall, Keiko, et al.
Publicado: (2023)

Understanding integrated service delivery: a scoping review of models for noncommunicable disease and mental health interventions in low-and-middle income countries
por: Adler, Alma J., et al.
Publicado: (2023)

Advancing Cardiovascular Disease Prevention, Management, and Control Through Field Epidemiology Training Programs in Noncommunicable Diseases in Low- and Middle-Income Countries
por: Acharya, Sushama D., et al.
Publicado: (2023)

The palm oil industry and noncommunicable diseases
por: Kadandale, Sowmya, et al.
Publicado: (2019)

Access to medicines for acute illness in middle income countries in Central America
por: Emmerick, Isabel Cristina Martins, et al.
Publicado: (2013)

Contraception for adolescents in low and middle income countries: needs, barriers, and access
por: Chandra-Mouli, Venkatraman, et al.
Publicado: (2014)

Improving access to affordable vaccines for middle-income countries in the african region
por: Mihigo, Richard, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3kvr769nj3dlpqe34979gukgfh